Sotera Health (NASDAQ:SHC) Stock Rating Upgraded by The Goldman Sachs Group
Sotera Health (NASDAQ:SHC – Get Free Report) was upgraded by analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report released on Monday, Marketbeat reports. The brokerage presently has a $17.00 price objective on the stock, up from their prior price objective of $14.00. The Goldman Sachs Group’s […]
Sotera Health (NASDAQ:SHC – Get Free Report) was upgraded by analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report released on Monday, Marketbeat reports. The brokerage presently has a $17.00 price objective on the stock, up from their prior price objective of $14.00. The Goldman Sachs Group’s […]
